I am currently Chief Medical Officer and SVP of Clinical Development and Regulatory Affairs
Until recently, I was VP Regulatory Oncology at Sanofi Pharmaceuticals managing a global group of approx 20 Senior Oncology Regulators and overseeing a oncology portfololio of approx 20 oncology assets. Before Sanofi, was Chief Medical Officer at Tokai Pharmaceuticals, responsible for Development activities of galeterone, an small molecule that targets the androgen receptor at 3 distinct levels.
Previously, I was Senior Medical Director, Oncology, at Astra Zeneca (AZ). I was responsible for the Life Cycle Management for vandetanib, a oral multikinase inhibitor approved for Medullary Thyroid Car...